Atlas Trials

Utility of Sortilin as a Biomarker of Restenosis After Lower Extremity Endovascular Revascularization

Clinical trial NCT05759130 · UNKNOWN

Trial details

NCT number
NCT05759130
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
UNKNOWN
Study type
OBSERVATIONAL
Peripheral Artery Disease
Start date
2019-10-24
Primary completion
2024-10-31
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.